Search filters

Filters
Clear All

Phase

  • 183
  • 156
  • 2
  • 194
  • 1
  • 148
  • 17
  • 396
  • 1237
  • 588
  • 29
  • 49
  • 3
  • 1162
  • 1237
  • 6
  • 3
  • 1240

Found 1243 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

 Study of AVB-S6-500 plus Nab-paclitaxel and Gemcitabine in Patients with Locally Advanced or Metastatic Pancreatic Adenocarcinoma
18 years - 99 years
All genders
Phase 1
Interventional
The purpose of this research study is to evaluate the safety, tolerability and efficacy of AVB-S6-500 combined with chemotherapies called nab-paclitaxel and gemcitabine in subjects with pancreatic cancer who have not received treatment previously.
 Policy to implementation: Evidence-based practice in community mental health
99 years or below
All genders
Observational
The overall objectives of the study are to identify 1) the impact of a policy mandate on individual provider implementation of evidence-based practices in community mental health clinics, 2) examine if organizational- and leader-level variables moderate implementation of evidence based practices, and 3) understand the implementation experience from the perspective …
 The Diaphragmatic Initiated Ventilatory Assist (Diva) Trial
99 years or below
All genders
Interventional
DIVA is a pragmatic randomized clinical trial (RCT) to determine: among (P) preterm infants born 24-27 6/7 weeks gestation undergoing extubation from mechanical ventilation, whether (I) Non-invasive neurally adjusted ventilatory assist (NIV-NAVA) (C) compared with Non-synchronized nasal intermittent positive pressure ventilation (NS-NIPPV), will reduce the incidence of (O) extubation failure …
18 years - 99 years
All genders
Observational
Adult patients with Rheumatoid Arthritis, Psoriatic Arthritis, SLE, Sjogren’s Disease, Multiple Sclerosis, Scleroderma, Vasculitis or Blistering Diseases will undergo a blood draw and collection of clinical information prior to receipt of COVID-19 vaccination. Subjects will undergo a repeat blood draw and collection of clinical information at 4-10 weeks, 6 months …
 Emergency Department-Initiated Buprenorphine Validation Network Trial
18 years - 99 years
All genders
Interventional
The purpose of this research study is to compare two versions of the same medication buprenorphine, (commonly known as Suboxone) used to treat opioid use disorder, in patients in the Emergency Department (ED). One form of the medication is a slow-release form of buprenorphine (CAM2038) that lasts for about 7 …
 A study of the ReCor Medical Paradise System in Clinical Hypertension
18 years - 99 years
All genders
Observational
The objective of TRIO CAP is to continue to collect safety and effectiveness data on the Paradise System in hypertensive subjects inadequately controlled with three antihypertensive medications, similar to those randomized in the RADIANCE-HTN Study TRIO Cohort, until the Paradise Ultrasound Renal Denervation System becomes commercially available. Reduction in average …
 Strategies in Patients undergoing repeat AF ablation
18 years - 99 years
All genders
Interventional
The aim of the proposed research project is to compare the efficacy of three different ablation strategies in patients with atrial fibrillation (AF) who are undergoing their first repeat catheter ablation for recurrent AF.
 Breethe Abiomed Recovery Trial
18 years - 99 years
All genders
Observational
The intent of the BART Study is to utilize observational data of the Abiomed Breethe OXY-1 System™ in real-world settings to drive best practice usage patterns identified through study analysis, to serve as a tool to measure and improve the quality of patient care and to serve as a resource …
 Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome (AEGIS-II)
18 years - 99 years
All genders
Phase 3
Interventional
This is a multicenter, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of CSL112 on reducing the risk of major adverse CV events (MACE) in subjects with Acute Coronary Syndrome (diagnosed with STEMI or NSTEMI), who are receiving evidence-based medical therapy.
 Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature (ELEGANCE)
18 years - 99 years
All genders
Observational
ELEGANCE is a global prospective, non-randomized, open-label, multi-center Registry to collect Real-World Data, including health economic data, to support the use of commercially available drug-eluting BSC devices for the treatment of lesions located in the peripheral vasculature
521 - 530 of 1243